Valeo Pharma Inc. (VPHIF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 02:43PM EDT
| Previous Close | 0.1120 |
| Open | 0.1145 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1145 - 0.1145 |
| 52 Week Range | 0.1000 - 0.5247 |
| Volume | |
| Avg. Volume | 684 |
| Market Cap | 11.296M |
| Beta (5Y Monthly) | 2.53 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2300 |
| Earnings Date | Jun 11, 2024 - Jun 17, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupVALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE
Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve Saviuk, Valeo's Chief Executive Officer, will present and participate in one-on-one meetings at the 2024 Bloom Burton & Co. Healthcare Investor Conference, which is scheduled to take place at the Metro Toronto Convention Centre in Toronto from April 16-17, 2024.
- Baystreet
Stocks in play: Valeo Pharma Inc.
Announced that Al Moghaddam has joined the Company's Board of Directors. Valeo Pharma Inc. shares T.VPH ...
CNW GroupVALEO PHARMA ANNOUNCES APPOINTMENT OF MR. AL MOGHADDAM TO BOARD OF DIRECTORS
Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al Moghaddam has joined the Company's Board of Directors.
© 2024 Yahoo. All rights reserved.